Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Dale G. Schaar"'
Autor:
Neil D. Palmisiano, Ju‐Whei Lee, David F. Claxton, Elisabeth M. Paietta, Hassan Alkhateeb, Jae Park, Nikolai A. Podoltsev, Ehab L. Atallah, Dale G. Schaar, Shira N. Dinner, Jonathan A. Webster, Selina M. Luger, Mark R. Litzow
Publikováno v:
eJHaem, Vol 5, Iss 5, Pp 951-956 (2024)
Abstract Introduction Relapsed or refractory (r/r) acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL) remains a therapeutic challenge. Preclinical data in both B‐ and T‐ALL suggests synergy of venetoclax (VEN) with vincristine (VCR
Externí odkaz:
https://doaj.org/article/c91b8c18158941c486ff17cf61cf66fd
Publikováno v:
Stem Cells International, Vol 2017 (2017)
Adult acute myeloid leukemia (AML) clinically is a disparate disease that requires intensive treatments ranging from chemotherapy alone to allogeneic hematopoietic cell transplantation (allo-HCT). Historically, cytogenetic analysis has been a useful
Externí odkaz:
https://doaj.org/article/50915b3380884c4e83d673c01e74019b
Autor:
Mary Kate McGrath, Dale G. Schaar, Yong Lin, Dennis L. Cooper, Tracy Krimmel, Jacqueline Manago, Anne Tyno, Roger Strair, Vimal Patel
Publikováno v:
Bone Marrow Transplantation. 56:1099-1105
The addition of posttransplant cyclophosphamide (PTCy) to standard graft-versus-host disease (GVHD) prophylaxis following haploidentical blood stem transplants has resulted in relatively low rates of GVHD. As GVHD remains a major cause of morbidity a
Publikováno v:
Clinical lymphoma, myelomaleukemia. 21(9)
Introduction The objective of the study was to assess the impact of the previous use of immune-checkpoint inhibitors (ICIs) on the clinical course of Hodgkin Lymphoma (HL) patients undergoing autologous hematopoietic stem cell transplantation (ASCT).
Autor:
Dale G. Schaar, Nikolai A. Podoltsev, Neil Palmisiano, Mark R. Litzow, Hassan B. Alkhateeb, Ehab Atallah, David F. Claxton, Jonathan Webster, Jae H. Park, Selina M. Luger, Ju-Whei Lee, Shira Dinner, Elisabeth Paietta
Publikováno v:
Blood. 138:3407-3407
Background: Relapsed or refractory (R/R) acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL) remain a therapeutic challenge, especially in elderly patients(pts) or those with T-cell immunophenotype. Inhibition of apoptosis is an increas
Publikováno v:
Stem Cells International, Vol 2017 (2017)
Stem Cells International
Stem Cells International
Adult acute myeloid leukemia (AML) clinically is a disparate disease that requires intensive treatments ranging from chemotherapy alone to allogeneic hematopoietic cell transplantation (allo-HCT). Historically, cytogenetic analysis has been a useful
Autor:
Patricia Lafaro, Dale G. Schaar, Brandi Handel, Patricia Andrews, Anne Tyno, Dennis L. Cooper, Roger Strair, Nicole McEntee, Vimal Patel
Publikováno v:
Blood. 136:39-40
Background/Aim: Clostridium difficile infection (CDI) is the leading cause of infectious diarrhea among hospitalized patients. Blood and Marrow Transplant patients appear to be one of the most vulnerable populations due to previous antimicrobial expo
Autor:
Vimal Patel, Dale G. Schaar, Joseph Aisner, Daniel J. Medina, Roger Strair, Arnold B. Rabson, Kevin A. David, Mecide Gharibo, Rajat Bannerji, Yong Lin, Kelly Walton
Publikováno v:
Leukemia & Lymphoma. 58:1227-1230
Nuclear factor kappa B (NF-κB) is constitutively expressed in many primary acute myelogenous leukemia (AML) and leukemic stem cell (LSC) samples. Inhibition of nuclear NF-κB ex vivo results in cyto...
Autor:
Dale G. Schaar, Vimal Patel, Dennis L. Cooper, Roger Strair, Anne Tyno, Mary Kate McGrath, Tracy Krimmel, Jackie Manago
Publikováno v:
Blood. 134:4485-4485
Background: The incorporation of PCy in IP has allowed transplantation of stem cells from haploidentical (HI) family members such that nearly all patients have a potential donor. Thus far, HI stem cell transplantation with PCy appears to yield compar
Publikováno v:
Journal of Clinical Oncology. 37:e18533-e18533
e18533 Background: Post transplant cyclophosphamide (PTCY) has been shown to be an effective treatment for prevention of graft versus host disease (GVHD). However, this increased immune suppression rates may increase the risk of CMV reactivation. The